Megadale makes equipment for the medtech and life-sciences sectors but a cancelled contract by a major multinational forced the company into liquidation.
The Waterford medtech company has brought on a new investor in US firm Five Arrows and is eyeing a major R&D and manufacturing expansion stateside.
Norway’s Verdane bought a majority stake in the Irish regtech company earlier this year. Chief executive John Byrne tells The Currency what the company’s priorities are now.
The Limerick-based and Toronto-listed firm builds software for the life sciences sector but said its business is dependent on a “relatively small number of customers”.
Perigord, which designs artwork for the life sciences sector, sold a majority stake to Indian giant Tech Mahindra last year for €21 million. It has brought fire power and even more ambition to the business, says Perigord CEO Alan Leamy.
The head of global agribusiness Alltech finds himself hosting the first virtual edition of his company’s popular annual industry conference. He discusses how food production can navigate “the next normal”, and why his $3 billion firm remains private even as it enters new areas of digital technology and medicine.
Integumen was on life support when Gerry Brandon spotted the potential of its skin cloning technology. He acquired it, and a year later the stock is up 1,252 per cent. What’s next?
© 2026 Currency Media Limited
